Cancer, Research, Nobel Prize, Immune System, Physiology.
continues to fund multiple research projects pursuing further understanding of the utility of checkpoint inhibitors in several types of blood cancers. Allison’s discoveries led to the development of the first FDA-approved checkpoint immunotherapy, the anti-CTLA-4 antibody known as ipilimumab